NCT01963078View on ClinicalTrials.gov

Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
PTSD
Interventions
DRUG

Oxytocin

DRUG

Placebo

Trial Locations (1)

29425

Clinical Neurosciences Division-Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Megan Moran-Santa Maria

OTHER

NCT01963078 - Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin | Biotech Hunter | Biotech Hunter